Etid klinik pou Menenjyom nan Florid
7 etid pou Menenjyom ap chèche patisipan nan sit nan Florid.
Vil nan Florid
Tèks ofisyèl etid la (Anglè)
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Boca Raton Regional Hospital, Boca Raton
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- Holy Cross Hospital, Fort Lauderdale
- ak 6 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT02523014Comparing the Radiopharmaceutical Drug, [177Lu]Lu-DOTATATE, to Standard of Care Treatment for Patients With Meningioma That Has Come Back After Prior Treatment
- Baptist MD Anderson Cancer Center, Jacksonville
- University of Miami, Miami
- Baptist Health Medical Group Oncology, Miami
- ak 1 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06955169A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- Mayo Clinic_Jacksonville, Jacksonville
- Baptist Health Miami Cancer Institute, Miami
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07428616Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
- University of Miami, Miami
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT04374305Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- BayCare Health, Clearwater
- Ascension St. Vincent's, Jacksonville
- Miami Cancer Institute, Baptist Health South Florida, Miami
- ak 4 plis
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Jul 22, 2026 · NCT04427384Cabozantinib for Patients With Recurrent or Progressive Meningioma
- Miami Cancer Institute at Baptist Health, Inc., Miami
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT05425004Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- Mayo Clinic, Jacksonville
- Biogenix Molecular, Miami
Ap rekriteFaz 1/2
Laj 18 a 90 · Tout sèks · Mizajou May 14, 2026 · NCT05636618Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.